Chegg CHGG Reports Strong Q1 2026 Revenue NA EPS Beats Feds Preferred Inflation Gauge Signals Stubborn Price Pressures HAB Pharma and Signature Phytochemicals Merger Expands Specialty Drug Manufacturing Capabilities Kevin Warshs Preferred Inflation Measure Could Backfire Bank of America Warns Solar Panel Sales Surge as CostConscious Consumers and Businesses Seek Energy Savings Consumer Sentiment Hits Record Low in May on Iran War Fears and Oil Price Surge Barclays Reaffirms Overweight Rating on Equity LifeStyle Properties CapitaLand Unveils 14 Billion Geneo Life Sciences Hub in Science Park Redevelopment Beyond Acquires Buy Buy Baby Brand Rights to Reunite with Bed Bath Beyond London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance Triumph Financial TFIN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Upexi UPXI Q1 2026 Earnings Massive EPS Miss Highlights Operational Challenges MBC Q1 2026 Earnings Profit Beat Defies Expectations Amid Cost Discipline Curis Inc Q1 2026 Earnings Deep EPS Miss as PreRevenue Biotech Continues Development Innovative Eyewear Inc LUCY Q1 2026 Earnings Narrowing Losses Lift Sentiment URBN Q1 2026 Earnings EPS Surges Past Estimates but Stock Dips Slightly Lear Corporation LEA Gains 172 as Shares Test MidRange Levels NMP Acquisition Corp Right NMPAR Sees Sharp 1154 Spike Key Levels Under Scrutiny Crane Harbor Acquisition Corp II Rights CRANR Holds Steady at 022 as Market Awaits Catalysts IQVIA Holdings IQV Holds Steady Near Support Amid Modest Decline Danaher DHR Slips Slightly Amid Broader Market Caution Key Support and Resistance Levels in Focus Proto Labs PRLB Edges Higher Testing Key Resistance Zone Art Technology Acquisition Warrants ARTCW Rally 606 to 035 Testing Key Resistance Hongli Group HLP Stock Slides 33 as Key Support Level Approaches Preferred Bank PFBC Edges Higher Consolidation Near Key Resistance Global Business Travel Group GBTG Holds Steady at 944 Amidst Consolidation Navigating Trust Taxation Strategies for Distributing 300000 Annual Income to Children C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline CSG Systems Holds Steady at 8069 as Support and Resistance Levels Come into Focus